Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 south-Transdanubian Hungarian inhabitants - PubMed (original) (raw)
. 2005 Nov-Dec;23(6):801-8.
Affiliations
- PMID: 16396698
Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 south-Transdanubian Hungarian inhabitants
L Czirják et al. Clin Exp Rheumatol. 2005 Nov-Dec.
Abstract
Objectives: To assess the prevalence of Raynaud's phenomenon (RP) and of RP associated systemic sclerosis (SSc) in a large regional representative study.
Methods: Ten thousand individuals aged between 14-65 years participated in face-to-face interviews. The stratified sample of the South-West Hungarian population was representative for age, sex and urban or rural residence. Individuals reporting complaints suggesting the presence of "clinically significant" RP were asked to undergo a clinical investigation. Patients showing complaints provoked by taking something out of the freezer (-20 degrees C) compartment of the refrigerator and/or whether they had experienced digital ulcers were sorted into this category.
Results: The overall prevalence of RP was at least 578.9/10,000, and the prevalence of "clinically significant" RP could be calculated as at least 87.7/10,000 inhabitants. In this latter group 17.2% of the cases had either established SSc or anticentromere antibody or scleroderma capillary pattern on nailfold capillaroscopy. SSc with "clinically significant" RP and/or ulcers was identified in a prevalence of 9.1/10.000 individuals, whilst there was a prevalence of 14.7/10,000 of RP with either anticentromere antibody or scleroderma capillary pattern.
Conclusions: "Clinically significant" RP affects almost 1% of the population. We identified cases with early stages of scleroderma spectrum disorder showing either anticentromere autoantibody or scleroderma capillary pattern. The prevalence of SSc was found to be higher than expected. It is reasonable to screen "clinically significant" RP cases for scleroderma-related symptoms because this approach makes it possible to identify patients with both SSc and early scleroderma related symptoms.
Similar articles
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Koenig M, et al. Arthritis Rheum. 2008 Dec;58(12):3902-12. doi: 10.1002/art.24038. Arthritis Rheum. 2008. PMID: 19035499 - Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirják L, Distler O, Walker UA, Fransen J, Allanore Y, Denton C, Cutolo M, Tyndall A, Müller-Ladner U, Matucci-Cerinic M; EUSTAR co-workers; EUSTAR co-workers. Minier T, et al. Ann Rheum Dis. 2014 Dec;73(12):2087-93. doi: 10.1136/annrheumdis-2013-203716. Epub 2013 Aug 12. Ann Rheum Dis. 2014. PMID: 23940211 - Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM; Scleroderma Clinical Trials Consortium. Merkel PA, et al. Arthritis Rheum. 2002 Sep;46(9):2410-20. doi: 10.1002/art.10486. Arthritis Rheum. 2002. PMID: 12355489 - Raynaud's phenomenon.
Hughes M, Herrick AL. Hughes M, et al. Best Pract Res Clin Rheumatol. 2016 Feb;30(1):112-32. doi: 10.1016/j.berh.2016.04.001. Epub 2016 May 11. Best Pract Res Clin Rheumatol. 2016. PMID: 27421220 Review.
Cited by
- Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network. López-Bastida J, et al. Eur J Health Econ. 2016 Apr;17 Suppl 1:109-17. doi: 10.1007/s10198-016-0789-y. Epub 2016 Apr 2. Eur J Health Econ. 2016. PMID: 27038626 - Social/economic costs and health-related quality of life in patients with rare diseases in Europe.
López-Bastida J, Oliva-Moreno J, Linertová R, Serrano-Aguilar P. López-Bastida J, et al. Eur J Health Econ. 2016 Apr;17 Suppl 1:1-5. doi: 10.1007/s10198-016-0780-7. Epub 2016 Mar 29. Eur J Health Econ. 2016. PMID: 27023708 No abstract available. - Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.
Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B. Magyari L, et al. World J Orthop. 2014 Sep 18;5(4):516-36. doi: 10.5312/wjo.v5.i4.516. eCollection 2014 Sep 18. World J Orthop. 2014. PMID: 25232528 Free PMC article. Review. - Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.
Allanore Y, Saad M, Dieudé P, Avouac J, Distler JH, Amouyel P, Matucci-Cerinic M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Wipff J, Lambert JC, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal-Bielecka O, Valentini G, Mouthon L, Czirják L, Damjanov N, Salvi E, Conti C, Müller M, Müller-Ladner U, Riccieri V, Ruiz B, Cracowski JL, Letenneur L, Dupuy AM, Meyer O, Kahan A, Munnich A, Boileau C, Martinez M. Allanore Y, et al. PLoS Genet. 2011 Jul;7(7):e1002091. doi: 10.1371/journal.pgen.1002091. Epub 2011 Jul 7. PLoS Genet. 2011. PMID: 21750679 Free PMC article. - [Capillaroscopy. Procedure and nomenclature].
Sander O, Sunderkötter C, Kötter I, Wagner I, Becker M, Herrgott I, Schwarting A, Ostendorf B, Iking-Konert C, Genth E. Sander O, et al. Z Rheumatol. 2010 May;69(3):253-62. doi: 10.1007/s00393-010-0618-0. Z Rheumatol. 2010. PMID: 20309697 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical